Acura Pharmaceuticals, Inc. (ACUR)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2018 2017
Revenue - 1.56 Million 3.57 Million 2.65 Million 410 Thousand 2.96 Million
Cost of Revenue - 1.21 Million 1781.00 1505.00 1759.00 128 Thousand
Gross Profit - 352 Thousand 3.56 Million 2.65 Million 408.24 Thousand 2.83 Million
Operating Expenses - 2.77 Million 4.32 Million 3.38 Million 4.32 Million 8.06 Million
Selling, General and Administrative Expenses - 1.25 Million 2.54 Million 1.87 Million 2.56 Million 4.34 Million
Research and Development Expenses - 1.52 Million 1.78 Million 1.5 Million 1.75 Million 3.72 Million
Other Expenses - - - - 296 Thousand -
Cost and Expenses - 2.77 Million 4.32 Million 3.38 Million 4.32 Million 8.19 Million
Operating Income - -1.21 Million -758 Thousand -725 Thousand -3.91 Million -5.22 Million
Interest Expense - 200 Thousand 450 Thousand 449 Thousand 223 Thousand 596 Thousand
Income Tax Expense - 200 Thousand 450 Thousand 176 Thousand 468 Thousand -135 Thousand
Earnings before Tax - -879 Thousand -1.2 Million -3.77 Million -3.84 Million -5.81 Million
Net Income - -1.07 Million -1.65 Million -3.95 Million -3.84 Million -5.68 Million
Earnings Per Share Basic - -0.02 -0.05 -0.15 -0.18 -0.36
Earnings Per Share Diluted - -0.02 -0.05 -0.15 -0.18 -0.36
Weighted Average Shares Outstanding - 56.8 Million 32.32 Million 26.72 Million 21.14 Million 15.9 Million
Weighted Average Shares Outstanding (Diluted) - 56.8 Million 32.32 Million 26.72 Million 21.14 Million 15.9 Million
Gross Margin - 0.23 1.00 1.00 1.00 0.96
EBIT Margin - -0.78 -0.18 -0.27 -8.83 -1.76
Profit Margin - -0.69 -0.46 -1.49 -9.37 -1.92
EBITDA - -589 Thousand -633 Thousand -3.03 Million -3.16 Million -4.92 Million
Earnings Before Tax Margin - -0.78 -0.21 -0.27 -9.55 -1.76

Income Statement Charts